Information in the press release below is intended for investors.
Isofol has obtained a request to call an extraordinary general meeting from shareholders representing a minority of at least 10 percent in order to take a decision on the election of a new board of directors. The notice to the extraordinary general meeting will be announced as soon as is practically possible.
For clarification, the board would like to point out that if the board's proposal for liquidation is not approved at the extraordinary general meeting called by the board on
For further information, please contact
Jan Törnell, styrelseordförande
E-mail: jan.tornell@innoext.se
Jarl Ulf Jungnelius, M.D., CEO
E-mail: jungnelius@isofolmedical.com
Telephone: +46 709-16 89 55
The information was submitted for publication, through the agency of the contact person set out above, on
About Isofol Medical AB (publ)
www.isofolmedical.com
https://news.cision.com/isofol-medical-ab--publ-/r/isofol-has-obtained-a-request-to-call-for-an-extraordinary-general-meeting,c3705470
https://mb.cision.com/Main/15598/3705470/1813469.pdf
(c) 2023 Cision. All rights reserved., source